Spago Nanomedical
Phase 1/2Spago Nanomedical is a Swedish company in clinical development phase with a proprietary platform of polymeric materials to bring more precise treatment and imaging diagnostics of cancer and other severe diseases.
Founded
2009
Focus
DiagnosticsNanotechnologyRadiopharmaceuticals
About
Spago Nanomedical is a Swedish company in clinical development phase with a proprietary platform of polymeric materials to bring more precise treatment and imaging diagnostics of cancer and other severe diseases.
Funding History
2Total raised: $13.7M
PIPE$5.2MUndisclosedOct 15, 2021
IPO$8.5MAvanzaJun 20, 2018
Company Info
TypePrivate
Founded2009
LocationLund, Sweden
StagePhase 1/2
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile